000 04605cam a2200445Ii 4500
001 94901
003 ES-MaUEC
005 20230102112637.0
006 m o d
007 cr cnu|||unuuu
008 161122t20162017sz ob 001 0 eng d
020 _a331944025X
_q(electronic bk.)
020 _a9783319440255
_q(electronic bk.)
020 _z9783319440231
_q(print)
035 _a(OCoLC)963932162
040 _aN$T
_cN$T
_dIDEBK
_dEBLCP
_dGW5XE
_dOCLCF
_dN$T
_dYDX
_dUAB
_dIOG
_dESU
_dZ5A
_dJBG
_dIAD
_dICW
_dICN
_dOTZ
_dOCLCQ
_dOHI
_dMERER
_dOCLCQ
_dU3W
_dES-MaUEC
_bspa
050 4 _aR1
_b2017 EB
245 0 0 _aSurgical emergencies in the cancer patient
_cYuman Fong, Rondi Marie Kauffmann, Emily Marcinkowski, Gagandeep Singh, Hans F. Schoellhammer, editors.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2016
264 4 _c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
504 _aIncluye referencias bibliográficas e índice
505 0 _aPreface; Foreword; Contents; Contributors; 1: Preoperative Evaluation of the Cancer Patient for Emergency Surgery; Introduction; The American Society of Anesthesiologists' Risk Classification; Preoperative Cardiovascular Risk Assessment; Coronary Artery Disease; Heart Failure; Valvular Heart Disease; Aortic Stenosis; Mitral Stenosis; Aortic Regurgitation and Mitral Regurgitation; Perioperative Fluid Management; Transfusions; Sepsis; Preoperative Pulmonary Evaluation; Airway Management; References; 2: Toxicity of Antineoplastic Therapy and Considerations for Perioperative Care
505 8 _aCancer Outcomes After Transfusions Implications of the Spleen in Regulation of Thrombocyte Counts and Spleen-Based Regulation of the Immune System; Summary; References; 5: Emergency Surgery After Previous Radiation Therapy; Identifying a Previously Irradiated Patient; Radiation Therapy Terminology; Basics of Radiation Exposure, Dose, and Types; Radiation Techniques and Terminology; Biology of Radiation Exposure of Normal Tissues; Skin; Mucosa; Muscles; Lymphatics; Evaluating the Previously Irradiated Patient for Consideration of Surgery; Overall Status of the Patient
505 8 _aEarly Postoperative Intraperitoneal Chemotherapy (EPOCH or EPIC) Summary; References; 3: Surgical Considerations and Emergencies in the Cancer Patient Receiving Immunotherapy; Introduction; Current Progress of Immunotherapy in Cancer; Overview of Immune Checkpoint Pathways; CTLA4 Axis; PD-1 Axis; Future Pathways of Interest; Current Immune Checkpoint Inhibitors Approved and in Development (Table 3.1); Ipilimumab; Tremelimumab; Nivolumab; Pembrolizumab; MEDI4736; BMS-936559; MPDL3280A; Gastrointestinal Toxicities from Immunotherapy (Table 3.2); CTLA4 Inhibitors
505 8 _aIntroduction Cytotoxic Agents and Potential Organ Toxicity; Hematologic Toxicity; Cardiac Toxicity; Anthracycline Antitumor Antibiotics; Alkylating Agents; Other Chemotherapeutic Agents with Potential Cardiotoxicity; Pulmonary Toxicity; Antitumor Antibiotics; Renal Toxicity; Platinum Agents; Neurologic Toxicity; Hepatic Toxicity; Specific Considerations in Perioperative Care; Corticosteroids; Agents with Anti-angiogenic Activity; Toxicity of Specific Chemotherapy Regimens; Hyperthermic Intraoperative Intraperitoneal Chemotherapy
505 8 _aPD-1/PD-L1 Inhibitors Combining CTLA4 and PD-1/PD-L1 Inhibitors; Therapeutic Strategies for Treatment of Immunotherapy-­Induced Colitis; Conclusions; References; 4: Surgery in the Thrombocytopenic and Coagulopathic Patient; Introduction; Background; Thrombocytopenia; Inherited Coagulopathies; Perioperative Acquired Coagulopathy; Therapeutic Anticoagulation; Warfarin; Unfractionated Heparin; Low-Molecular-Weight Heparins; Fondaparinux; Direct Xa Inhibitors; Direct Thrombin Inhibitors; Hemostatic Agents and Devices; Current Recommendations for Transfusions
650 7 _aCáncer
_xCirugía
_2embne
_0(OCoLC)fst00845532
_0
_9175031
700 1 _aFong, Yuman
_eeditor literario
_994724
700 1 _aKauffmann, Rondi Marie.
_eeditor literario
700 1 _aMarcinkowski, Emily,
_eeditor literario
700 1 _aSchoellhammer, Hans F.,
_eeditor literario
700 1 _aSingh, Gagandeep,
_cMD,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-44025-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c94901
_d94901
_x1